EastWest Bioscience Inc. (HBOSF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
EastWest Bioscience Inc. (HBOSF) trades at $0.00 with AI Score 35/100 (Grade D). EastWest Bioscience Inc. is a vertically-integrated wellness company focused on manufacturing and selling hemp nutritional products in Canada and the United States. Market cap: $7,780, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for HBOSF: HBOSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HBOSF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HBOSF: 1/1 perspectives are bearish.
How is this calculated? →EastWest Bioscience Inc. (HBOSF) Healthcare & Pipeline Overview
EastWest Bioscience Inc. operates as a vertically-integrated wellness company, manufacturing and distributing hemp-based nutritional products and supplements. The company's operations include retail through Sangster's Health Center franchise stores and online sales, positioning it within the competitive health and wellness market in North America.
What Is the Investment Thesis for HBOSF?
Investing in EastWest Bioscience Inc. (HBOSF) presents a high-risk, high-reward scenario. The company's focus on the hemp-based nutritional product market offers growth potential, but its current financial metrics raise concerns. With a negative P/E ratio of -0.01 and a substantial negative profit margin of -256.2%, the company's profitability is a significant challenge. The low gross margin of 4.5% indicates cost pressures. A potential growth catalyst is the expansion of Sangster's Health Center franchise network and online sales. However, investors should closely monitor the company's ability to improve its financial performance and manage its operational costs. The stock's beta of 0.71 suggests lower volatility compared to the overall market.
Based on FMP financials and quantitative analysis
HBOSF Key Highlights
- Market Cap of 8K indicates the company's small size and potential for high growth but also higher risk.
- P/E Ratio of -0.01 reflects the company's current lack of profitability.
- Profit Margin of -256.2% signals significant operational challenges and high expenses relative to revenue.
- Gross Margin of 4.5% indicates a limited ability to generate profit from sales after accounting for the cost of goods sold.
- Beta of 0.71 suggests the stock is less volatile than the market average.
Who Are HBOSF's Competitors?
HBOSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
| NEUP Neuphoria Therapeutics Inc. | $3.44 | +1.78% | $18.59M | 60 |
| YI 111, Inc. | $4.13 | -0.12% | $36.04M | 44 |
| ALBHF Alibaba Health Information Technology Limited | $0.42 | +2.44% | $6.77B | 45 |
| WBA Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company | $11.98 | +0.50% | $10.37B | 45 |
| IPXL Impax Laboratories, Inc. | $18.30 | +0.55% | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HBOSF's Key Strengths?
- Vertically-integrated operations.
- Retail presence through Sangster's Health Center.
- Focus on hemp-based nutritional products.
- Established presence in Canada and the United States.
What Are HBOSF's Weaknesses?
- Negative profitability.
- Low gross margin.
- Small market capitalization.
- Limited brand recognition.
What Could Drive HBOSF Stock Higher?
- Expansion of Sangster's Health Center franchise network, increasing retail presence.
- Increased online sales through e-commerce platform, broadening market reach.
- Product innovation and development, introducing new hemp-based nutritional products.
- Strategic partnerships and acquisitions, expanding product offerings and market access.
- Expansion into new geographic markets, tapping into growing demand for natural health products.
What Are the Key Risks for HBOSF?
- Negative profitability and low gross margin, indicating financial challenges.
- Intense competition in the health and wellness industry, requiring differentiation.
- Changing regulations regarding hemp-based products, impacting market access.
- Economic downturn affecting consumer spending, reducing demand for discretionary products.
- Supply chain disruptions, affecting production and distribution.
What Are the Growth Opportunities for HBOSF?
- Expansion of Sangster's Health Center Franchise Network: Growing the number of Sangster's Health Center franchise locations represents a significant growth opportunity for EastWest Bioscience. Each new franchise increases the company's retail footprint and brand visibility. The health and wellness market is projected to reach $7 trillion globally by 2025, providing a large addressable market for new franchise locations. The company can focus on strategic locations in underserved markets to maximize impact. Timeline: Ongoing.
- Increased Online Sales Through E-Commerce Platform: Enhancing the company's e-commerce platform to drive online sales is crucial. The global e-commerce market is expected to continue its strong growth trajectory, offering EastWest Bioscience a cost-effective way to reach a broader customer base. Investing in digital marketing, improving website user experience, and offering exclusive online promotions can boost sales. The company should also explore partnerships with online retailers. Timeline: Ongoing.
- Product Innovation and Development: Introducing new and innovative hemp-based nutritional products can attract new customers and increase sales. The market for functional foods and beverages is growing rapidly, driven by consumer demand for health-enhancing products. EastWest Bioscience can invest in research and development to create unique formulations and delivery methods. Collaborating with research institutions and universities can accelerate the innovation process. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with other companies in the health and wellness industry can expand EastWest Bioscience's reach and product offerings. Acquisitions of complementary businesses can provide access to new markets, technologies, and distribution channels. The company should focus on partnerships that align with its core competencies and strategic goals. Timeline: Ongoing.
- Expansion into New Geographic Markets: Expanding into new geographic markets, particularly in Europe and Asia, represents a significant growth opportunity. These markets have a growing demand for natural health products and supplements. EastWest Bioscience can leverage its existing product portfolio and brand to enter these markets. Conducting market research and adapting products to local preferences are essential for success. Timeline: Ongoing.
What Opportunities Does HBOSF Have?
- Expansion of Sangster's Health Center franchise network.
- Increased online sales through e-commerce platform.
- Product innovation and development.
- Strategic partnerships and acquisitions.
What Threats Does HBOSF Face?
- Intense competition in the health and wellness industry.
- Changing regulations regarding hemp-based products.
- Economic downturn affecting consumer spending.
- Supply chain disruptions.
What Are HBOSF's Competitive Advantages?
- Vertically-integrated operations provide control over the supply chain.
- Sangster's Health Center franchise network offers a retail distribution channel.
- Focus on hemp-based nutritional products differentiates the company.
- Established presence in Canada and the United States.
What Does HBOSF Do?
EastWest Bioscience Inc., established in 2016 and headquartered in Penticton, Canada, is a vertically-integrated wellness company that focuses on the production and distribution of hemp-based nutritional products. The company's core business revolves around manufacturing and selling these products in both Canada and the United States. EastWest Bioscience also operates Sangster's Health Center, a chain of retail stores offering a range of supplements and wellness products. These stores are run as franchises, supplemented by an online e-commerce platform to broaden market reach. In addition to its wellness product lines, EastWest Bioscience is involved in property management, diversifying its business interests. The company's vertically-integrated structure allows it to control various stages of the production and distribution process, from manufacturing to retail sales, potentially improving efficiency and profitability. However, the company's small market capitalization and negative profitability indicate it is still in a growth phase with associated risks.
What Products and Services Does HBOSF Offer?
- Manufactures hemp nutritional products.
- Sells hemp nutritional products in Canada and the United States.
- Operates Sangster's Health Center stores.
- Sells supplements and wellness products through franchise locations.
- Operates an online e-commerce platform.
- Involved in property management.
How Does HBOSF Make Money?
- Manufacturing and selling hemp-based nutritional products.
- Franchising Sangster's Health Center stores.
- Generating revenue through retail sales of supplements and wellness products.
- Online sales through e-commerce platform.
What Industry Does HBOSF Operate In?
EastWest Bioscience Inc. operates within the competitive and rapidly evolving health and wellness industry, specifically targeting the hemp-based nutritional products market. This market has seen significant growth due to increasing consumer interest in natural health solutions. However, the industry is also characterized by intense competition from established players and new entrants. EastWest Bioscience's vertically-integrated model and retail presence through Sangster's Health Center provide a degree of differentiation. The company's success will depend on its ability to effectively market its products, manage costs, and navigate the regulatory landscape surrounding hemp-based products.
Who Are HBOSF's Key Customers?
- Health-conscious consumers seeking natural supplements.
- Individuals interested in hemp-based nutritional products.
- Franchise owners of Sangster's Health Center stores.
- Online shoppers looking for wellness products.
Company Profile
EastWest Bioscience Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Rodney Gelineau. HBOSF has traded publicly since 2023.
EastWest Bioscience Inc. (HBOSF) Valuation Context
Valued at 8K, HBOSF is classified as a micro-cap stock. Relative to its peer group, HBOSF's quantitative score of 35/100 is below the peer average of 59/100.
Key Financial Metrics
Return on assets is -43.1%, showing how much profit it generates from its asset base. A current ratio of 0.40 means current liabilities exceed short-term assets, a liquidity point worth watching.
HBOSF Financials
Bull Case vs Bear Case
Bull Case
- EastWest Bioscience seems to be gaining traction in online communities, with more users discussing potential partnerships and expansions.
- Recent insider buying activity could signal confidence within the company about future performance.
- The overall market sentiment towards health and wellness companies appears positive, which could benefit EastWest Bioscience.
- There's a growing buzz around their product lines in social media, suggesting increasing consumer interest and brand recognition.
Bear Case
- Community discussions reveal concerns about the company's ability to scale production to meet potential demand.
- Some investors are worried about increasing competition in the CBD and wellness market, potentially impacting EastWest Bioscience's market share.
- There are lingering questions in online forums about the company's long-term financial sustainability and profitability.
- A few posts highlight negative customer experiences, which could damage the brand's reputation if not addressed promptly.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
HBOSF Latest News
No recent news available for HBOSF.
HBOSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HBOSF.
Price Targets
Wall Street price target analysis for HBOSF.
HBOSF MoonshotScore
What does this score mean?
The MoonshotScore rates HBOSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Rodney Gelineau
CEO
Rodney Gelineau serves as the CEO of EastWest Bioscience Inc. His professional background includes experience in business development and management. He has been involved in various entrepreneurial ventures, focusing on the health and wellness sector. Gelineau's expertise lies in strategic planning, market analysis, and operational efficiency. He is responsible for guiding the company's overall direction and growth strategy. His leadership aims to capitalize on the increasing demand for hemp-based nutritional products.
Track Record: Under Rodney Gelineau's leadership, EastWest Bioscience Inc. has focused on expanding its product line and distribution channels. Key milestones include the development of new hemp-based products and the growth of the Sangster's Health Center franchise network. Gelineau has also overseen the company's efforts to increase online sales through its e-commerce platform. The company's financial performance remains a challenge, with ongoing efforts to improve profitability and manage costs.
HBOSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that EastWest Bioscience Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. This tier is generally considered the most speculative segment of the OTC market.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in HBOSF.
- Low liquidity can make it difficult to buy or sell shares at desired prices.
- OTC Other tier classification indicates a higher risk of fraud or manipulation.
- Small market capitalization increases volatility and potential for price swings.
- Lack of regulatory oversight compared to major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Check for any legal or regulatory issues involving the company.
- Review the company's OTC Markets profile for disclosures and compliance.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Operation of Sangster's Health Center franchise network.
- Manufacturing and selling hemp nutritional products.
- Established presence in Canada and the United States.
- Company has been in operation since 2016.
- CEO is identified and has a professional background.
HBOSF Healthcare Stock FAQ
What does EastWest Bioscience Inc. do?
EastWest Bioscience Inc. operates as a vertically-integrated wellness company focused on the hemp-based nutritional product market. The company manufactures and sells hemp nutritional products in Canada and the United States. Additionally, it operates Sangster's Health Center stores, which are franchised retail outlets selling supplements and wellness products. The company also has an online e-commerce platform to further distribute its products. This integrated approach allows EastWest Bioscience to control its supply chain and distribution channels, but the company's financial performance needs to improve.
What do analysts say about HBOSF stock?
Currently, there is no available analyst coverage or consensus on HBOSF stock. Given the company's small market capitalization, OTC listing, and limited financial disclosure, it is less likely to be actively tracked by major financial analysts. Investors should rely on their own due diligence and independent research to assess the company's prospects and risks. Key valuation metrics to consider include revenue growth, gross margin, and profitability trends, as well as the company's ability to execute its growth strategy.
What are the main risks for HBOSF?
Investing in HBOSF carries several significant risks. The company's negative profitability and low gross margin indicate financial instability. Intense competition in the health and wellness industry requires EastWest Bioscience to differentiate its products and marketing strategies. Changing regulations regarding hemp-based products could impact the company's ability to operate and sell its products. The OTC listing and limited financial disclosure add further risk due to the lack of regulatory oversight and potential for manipulation. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for HBOSF?
EastWest Bioscience Inc. (HBOSF) holds an AI score of 35/100 (low). Not financial advice.
How frequently does HBOSF data refresh on this page?
HBOSF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven HBOSF's recent stock price performance?
EastWest Bioscience Inc. (HBOSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically-integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HBOSF overvalued or undervalued right now?
Valuing EastWest Bioscience Inc. (HBOSF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying HBOSF?
Before investing in EastWest Bioscience Inc. (HBOSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- OTC market stocks carry higher risks than exchange-listed stocks.
- Analyst coverage is currently unavailable.